Amsterdam, December 3, 2015 - Graphene oxide could be used to make super strong dental fillings that don't corrode, according to a new study published in Colloids and Surfaces B: Biointerfaces.
Research suggests we chew around 800 times in an average meal; that's almost a million times a year. We put our teeth under huge strain, and often require fillings to repair them. Fillings are typically made of a mixture of metals, such as copper, mercury, silver and tin, or composites of powdered glass and ceramic.
Typical metal fillings can corrode and composite fillings are not very strong; Graphene on the other hand is 200 times stronger than steel and doesn't corrode, making it a prime new candidate for dental fillings.
In the study, researchers from Iuliu Hatieganu University of Medicine and Pharmacy, the National Institute for Research and Development of Isotopic and Molecular Technologies, and the University of Agricultural Sciences and Veterinary Medicine in Romania, and Ross University School of Veterinary Medicine Basseterre in the West Indies investigated whether different forms of graphene are toxic to teeth.
"The idea of the project was to add graphene into dental materials, in order to increase their resistance to corrosion as well as to improve their mechanical properties," explained Dr. Stela Pruneanu, one of the authors of the study from the National Institute for Research and Development of Isotopic and Molecular Technologies in Romania. "There is contradictory information regarding the cytotoxicity of graphene, so we first wanted to determine how toxic it is for teeth."
Graphene comes in different forms, including graphene oxide, nitrogen-doped graphene and thermally reduced graphene oxide. The researchers tested how toxic these different types of graphene are in vitro for stem cells found in teeth.
Thermally reduced graphene oxide was highly toxic, making it inappropriate as a dental filling material. Nitrogen-doped graphene caused membrane damage at high doses (20 and 40 micrograms per milliliter). However, it was shown to have antioxidant properties, so it could be useful if covered in a protective layer. Graphene oxide was least toxic to cells, making it an ideal candidate.
"The results were very interesting and proved that graphene is appropriate for use in dental materials," said Dr. Gabriela Adriana Filip, one of the authors of the study and Associate Professor at Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca in Romania. "We believe that this research will bring new knowledge about the cytotoxic properties of graphene-based materials and their potential applications in dental materials."
The next step for this research is for the team to make dental materials with graphene oxide and test how compatible they are with teeth, and how toxic they are to cells. The results are due to be published soon.
The research was part of a project entitled "New nanocomposites based on biocompatible polymers and graphene for dental applications," funded by MEN-UEFISCDI, Romania.
"Cytotoxicity assessment of graphene-based nanomaterials on human dental follicle stem cells" by Diana Olteanu, Adriana Filip, Crina Socaci, Alexandru Radu Biris, Xenia Filip, Maria Coros, Marcela Corina Rosu, Florina Pogacean, Camelia Alb, Ioana Baldea, Pompei Bolfa and Stela Pruneanu (doi: 10.1016/j.colsurfb.2015.10.023). The article appears in Colloids & Surfaces B: Biointerfaces, Volume 136 (December 2015), published by Elsevier.
A copy of the paper is available to credentialed journalists upon request, contact Elsevier's Newsroom at email@example.com or +31 20 4853564.
About Colloids and Surfaces B: Biointerfaces
Colloids and Surfaces B: Biointerfaces is an international journal devoted to fundamental and applied research on colloid and interfacial phenomena in relation to systems of biological origin, having particular relevance to the medical, pharmaceutical, biotechnological, food and cosmetic fields.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries.
+31 20 485 2053